| Application no. and date | 16702812.5 (espacenet) (Federated) (European Patent Register), 20160128 | | Patent/reg. no. and date | DK/EP 3250592, 20221005 | | Publication date | 20171206 | | Priority no. and date | US 201562109002 P, 20150128, US 201562266556 P, 20151211 | | EP pub. no. and date |
EP 3250592 20171206 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK,
University Health Network, 190 Elizabeth Street
R. Fraser Elliott Building - Room 1S-417
Toronto, Ontario M5G 2C4, CA | | Applicant ref. no. | 167459/BT/SD | | Inventor | NIJJAR, Tarlochan S., 712 Ironbark Court
Orinda, California 94563, US,
LIU, Yue, 815 Peary Lane
Foster City, California 94404, US,
CHAKRABARTTY, Avijit, 77 Points O'Woods Drive
Vaughn, Ontario L4K 2E1, CA,
HIGAKI, Jeffrey, N., 2071 Queens Lane
San Mateo, CA 94402, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07K 16/18 (2006.01) | | Title | ANTI-TRANSTHYRETIN-ANTISTOFFER | | Int. application no. | IB2016050415 | | Int. publication no. | WO2016120810 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
